FDA Inspectors Boost Scrutiny of Drugmakers’ Supplier Controls

Drug Industry Daily
Amid continuing concern that breaks in the global supply chain will beget another heparin crisis, FDA inspectors are upping scrutiny of drug manufacturers’ supplier controls to ensure they are sufficiently robust and clearly articulated in scientific terms, agency officials say.

To View This Article:


Subscribe To Drug Industry Daily